In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Transition Therapeutics Inc.

http://www.transitiontherapeutics.com/

Latest From Transition Therapeutics Inc.

Senti Bio Raises $105m Series B Round For CAR-NKs, Led By Leaps For Bayer

The investment is the latest in Bayer’s series of moves into cell and gene therapy, amid growing industry interest in CAR-NKs.

BioPharmaceutical Cancer

Coronavirus Update: Moderna Snags Vaccine EUA

The FDA granted emergency authorization for Moderna's mRNA-1273 following a 17 December advisory committee vote in its favor. There have also been more supply deals and approvals in Asia.

Coronavirus COVID-19 Infectious Diseases

Kantaro Sees Important Role For New Antibody Test During Next Phase Of Pandemic

The company is planning to produce up to 10 million COVID-SeroKlir SARS-CoV-2 IgG antibody test kits a month through a partnership with Bio-Techne.

Coronavirus COVID-19 Clinical Trials

FDA Releases COVID-19 Test Performance Data

The data compares the sensitivity of almost 200 diagnostics against a standardized set of samples.

Regulation In Vitro Diagnostics
See All

Company Information

  • Industry
  • Services
  • Other Names / Subsidiaries
    • Waratah Pharmaceuticals Inc.
UsernamePublicRestriction

Register